DiNicolantonio JJ - Search Results

1

Ezetimibe plus moderate-dose simvastatin after acute coronary syndrome: what are we IMPROVEing on?

DiNicolantonio JJ, Chatterjee S, Lavie CJ, Bangalore S, O'Keefe JH. DiNicolantonio JJ, et al. Am J Med. 2015 Aug;128(8):914.e1-4. doi: 10.1016/j.amjmed.2015.01.034. Epub 2015 Feb 27. Am J Med. 2015. PMID: 25731133

2

Optimal aspirin dose in acute coronary syndromes: an emerging consensus.

DiNicolantonio JJ, Norgard NB, Meier P, Lavie CJ, O'Keefe JH, Niazi AK, Chatterjee S, Packard KA, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Bangalore S, Fuchs FD, Serebruany VL. DiNicolantonio JJ, et al. Future Cardiol. 2014 Mar;10(2):291-300. doi: 10.2217/fca.14.7. Future Cardiol. 2014. PMID: 24762255 Review.

3

Statins, Ezetimibe, and Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors to Reduce Low-Density Lipoprotein Cholesterol and Cardiovascular Events.

O'Keefe JH, DiNicolantonio JJ, Lavie CJ. O'Keefe JH, et al. Among authors: dinicolantonio jj. Am J Cardiol. 2017 Feb 15;119(4):565-571. doi: 10.1016/j.amjcard.2016.11.001. Epub 2016 Nov 23. Am J Cardiol. 2017. PMID: 28081940

4

The History of the Salt Wars.

DiNicolantonio JJ, O'Keefe JH. DiNicolantonio JJ, et al. Am J Med. 2017 Sep;130(9):1011-1014. doi: 10.1016/j.amjmed.2017.04.040. Epub 2017 May 22. Am J Med. 2017. PMID: 28545886 Review.

5

Does Fish Oil Reduce the Risk of Cardiovascular Events and Death? Recent Level 1 Evidence Says Yes: PRO: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease.

DiNicolantonio J, O'Keefe JH. DiNicolantonio J, et al. Mo Med. 2021 May-Jun;118(3):214-218. Mo Med. 2021. PMID: 34149080 Free PMC article.

6

The Flaws of Recent Omega-3 Clinical Trials Should Not Prevent Their Use.

DiNicolantonio J, O'Keefe JH. DiNicolantonio J, et al. Mo Med. 2021 Jul-Aug;118(4):322. Mo Med. 2021. PMID: 34373664 Free PMC article. No abstract available.

7

Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.

Dinicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH, Bangalore S, Messerli FH. Dinicolantonio JJ, et al. Am J Cardiol. 2013 Oct 15;112(8):1230-4. doi: 10.1016/j.amjcard.2013.05.067. Epub 2013 Jul 2. Am J Cardiol. 2013. PMID: 23827403 Review.

8

Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality.

O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. O'Keefe JH, et al. Among authors: dinicolantonio jj. J Am Coll Cardiol. 2013 Sep 17;62(12):1043-1051. doi: 10.1016/j.jacc.2013.06.035. Epub 2013 Jul 17. J Am Coll Cardiol. 2013. PMID: 23871889 Free article. Review.

9

Neutralizing the adverse prognosis of coronary artery calcium.

Bhatti SK, DiNicolantonio JJ, Captain BK, Lavie CJ, Tomek A, O'Keefe JH. Bhatti SK, et al. Among authors: dinicolantonio jj. Mayo Clin Proc. 2013 Aug;88(8):806-12. doi: 10.1016/j.mayocp.2013.05.019. Mayo Clin Proc. 2013. PMID: 23910408

10

Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.

Dinicolantonio JJ, Lavie CJ, O'Keefe JH. Dinicolantonio JJ, et al. Postgrad Med. 2013 Jul;125(4):154-68. doi: 10.3810/pgm.2013.07.2687. Postgrad Med. 2013. PMID: 23933903 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page